AKT1 and cancer: The phosphoinositide 3-kinase (PI3K)-AKT signaling pathway is widely acknowledged as a most commonly elevated one in human cancers, including CRC, and it is essential in cell survival and growth as well as in glucose metabolism and anabolic metabolism [13,14].